Geoffrey E. Harris, Director at CANCER GENETICS, INC (CGIX), bought 2,500 shares at $1.50 ($4K) on 2016-12-14, disclosed to the SEC on 2016-12-14.
Open-market purchase of $4k CGIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| MYND | BUY | 2017-12-07 | $17K | — | Filing → |
| CGIX | BUY | 2017-05-16 | $9K | — | Filing → |
| CGIX | BUY | 2016-11-16 | $8K | — | Filing → |